Studies from our lab and others identified heterozygous germline mutations in SAMD9 (sterile α motif domain–containing 9) and its paralog, SAMD9L, in 8% to 20% of primary pediatric MDS patients with deletions of chr7 (4, 5). This evidence concerns the gene SAMD9L and myelodysplastic syndrome.